Clinico-Epidemiological Comparison of Delusion-Prominent and Hallucination-Prominent Clinical Subgroups of Paranoid Schizophrenia [0.03%]
以妄想或幻觉为主的精神分裂症偏执型患者的临床流行病学特征比较研究
Anatoly Kreinin,Vladimir Krishtul,Zvi Kirsh et al.
Anatoly Kreinin et al.
Background: Though hallucinations and delusions are prominent basic impairments in schizophrenia, reports of the relationship between hallucinatory and delusional symptoms among schizophrenia patients are scant. ...
Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: A case report [0.03%]
合成大麻素引起的精神病和严重横纹肌溶解症的一例报告
Dante Durand,Leticia L Delgado,Dhizarah Matus de la Parra-Pellot et al.
Dante Durand et al.
Background: Synthetic cannabinoid (SC) or "spice" refers to a variety of herbal/chemical mixtures, which mimic the effects of marijuana. They are generally marked as "herbal incense" and best known by the brand names of "...
Metacognitive training for delusion in treatment-resistant schizophrenia [0.03%]
治疗抵抗型精神分裂症患者的认知训练疗法
Devvarta Kumar,Mukund G Rao,Dhanya Raveendranathan et al.
Devvarta Kumar et al.
Metacognitive training for patients with schizophrenia (MCT) is a novel form of psychotherapy that aims to promote insight into the relationship between metacognitive deficits and psychotic symptoms, especially delusions. MCT has been found...
Brian Kirkpatrick,Brian Miller,Clemente García-Rizo et al.
Brian Kirkpatrick et al.
The concept of schizophrenia that is most widely taught is that it is a disorder in which psychotic symptoms are the main problem, and a dysregulation of dopamine signaling is the main feature of pathophysiology. However, this concept limit...
Ten-Year Quality-of-Life Outcomes of Patients with Schizophrenia and Schizoaffective Disorders: The Relationship with Unmet Needs for Care [0.03%]
精神分裂症和分裂情感障碍患者的十年生活质量结局与其护理需求之间的关系
Michael S Ritsner,Alexander Grinshpoon
Michael S Ritsner
Purpose: The present study examined the relationship between unmet needs and current as well as long-term quality of life (QOL) of patients with schizophrenia (SZ) and schizoaffective (SA) disorders. ...
William R Keller,Carol Vidal,Eric S Park et al.
William R Keller et al.
Meta-Analysis of Efficacy of Mirtazapine as an Adjunctive Treatment of Negative Symptoms in Schizophrenia [0.03%]
米氮平作为辅助治疗改善精神分裂症阴性症状有效性的元分析研究
Carol Vidal,Carla Reese,Bernard A Fischer et al.
Carol Vidal et al.
Context: Despite advances made in treating the positive symptoms of schizophrenia, treatment of negative symptoms remains an unmet therapeutic need. Adjunctive mirtazapine has shown promise for treatment of negative sympt...
Amresh Shrivastava,Megan Johnston,Kristen Terpstra et al.
Amresh Shrivastava et al.
Cannabis has been implicated as a risk factor for the development of schizophrenia, but the exact biological mechanisms remain unclear. In this review, we attempt to understand the neurobiological pathways that link cannabis use to schizoph...
Tatiana Falcone,Erin Carlton,Catherine Lee et al.
Tatiana Falcone et al.
Context: Human and animal studies have suggested an underlying inflammatory mechanism for a variety of neuropsychiatric disorders, including schizophrenia. To date, most available reports focused on adult patients. ...
Mary V Seeman,Rina Gupta
Mary V Seeman
Objective: Recognizing that needs differ between men and women with schizophrenia and that they vary over time, this review attempts to categorize the needs that are relevant to younger and to older women. ...